Injectable Thermosensitive Hydrogel Synergizes Antibacterial Action with Microenvironment Remodeling in Infected Diabetic Wounds
Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5657-5673
DOI: 10.1021/acs.molpharmaceut.6c00775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.10.2026. Verfasst von Xiaoyang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Harbin Medical University, Harbin150081, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Hydrogels, Diabetes Mellitus, Experimental, Wound Infection. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Program for Young Talents of Basic Research in Universities of Heilongjiang Province, National Natural Science Foundation of China (NSFC), Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Chronic wounds represent substantial clinical challenges due to their intricate pathophysiology, characterized by persistent infection, sustained inflammation, and compromised tissue regeneration. To overcome these obstacles, we developed an injectable thermosensitive hydrogel system (MR-NPs-Gels), incorporating engineered PLGA nanoparticles (MR-NPs) for the co-delivery of mupirocin, a first-line antibacterial agent, and l-arginine, a nitric oxide (NO) precursor. The MR-NPs-Gels exhibited favorable injectability, tissue adaptability, and ideal rheological properties. MR-NPs penetrated deep into tissues to exert antibacterial effects, while l-arginine released from them generated NO to exert anti-inflammatory and pro-angiogenic effects. In diabetic wound models, MR-NPs-Gels achieved a 77.39 ± 1.19% wound closure rate and more than 80% reduction in bacterial colony counts by day 9. Compared with commercial mupirocin ointment, this hydrogel significantly downregulated pro-inflammatory cytokines IL-6 and TNF-α, while upregulating angiogenic markers VEGF and CD31. Collectively, the co-delivery of mupirocin and l-arginine within MR-NPs-Gels enhances bacterial clearance and remodels the wound microenvironment synergistically, offering a promising topical therapeutic strategy for infected chronic wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Harbin Medical University, Harbin150081, China.
- Department of Pharmacy, the Second Affiliated Hospital, Harbin Medical University (Key Laboratory of Medications Research, College of Heilongjiang Province), Harbin150086, China.
ORCID-Profile: Hongyu Ji, Congcong Lin
Förderung
- Program for Young Talents of Basic Research in Universities of Heilongjiang Province
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Li, X., Ming, Y., Wang, X., Li, R., Yang, Y., Yang, T., Wang, J., Chang, B., Zhang, Q., Tang, J., Liu, J., Ji, H., & Lin, C. (2026). Injectable Thermosensitive Hydrogel Synergizes Antibacterial Action with Microenvironment Remodeling in Infected Diabetic Wounds. Molecular Pharmaceutics, 23(11), 5657-5673. https://doi.org/10.1021/acs.molpharmaceut.6c00775
Vancouver
Li X, Ming Y, Wang X, Li R, Yang Y, Yang T, et al. Injectable Thermosensitive Hydrogel Synergizes Antibacterial Action with Microenvironment Remodeling in Infected Diabetic Wounds. Molecular Pharmaceutics. 2026;23(11):5657-5673. doi:10.1021/acs.molpharmaceut.6c00775
BibTeX
@article{Li2026,
author = {Li, Xiaoyang and Ming, Yan and Wang, Xiaodan and Li, Rongtao and Yang, Yun and Yang, Teng and Wang, Jing and Chang, Baiyu and Zhang, Qing and Tang, Jingling and Liu, Jiaxin and Ji, Hongyu and Lin, Congcong},
title = {Injectable Thermosensitive Hydrogel Synergizes Antibacterial Action with Microenvironment Remodeling in Infected Diabetic Wounds},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {11},
pages = {5657--5673},
doi = {10.1021/acs.molpharmaceut.6c00775}
}
EUVIMED